Liver/Gut Inflammation and Fibrosis Research Group

About the Liver/Gut Inflammation and Fibrosis Research Group

Liver fibrosis and cirrhosis is the common end stage to all liver diseases in humans. We study mechanisms of liver fibrosis and factors that determine its progression to cirrhosis.

The Liver/Gut Inflammation and Fibrosis Research Group has been continuously active over ten  years and regularly contributes to international trials of new antiviral  agents for hepatitis B and C in addition to developing and leading  national investigator-initiated studies.

Group head

Professor William Sievert

Professor Sievert has a long-term interest in liver disease and directs  an active clinical research unit comprising physician-scientists,  clinical research nurses and research students. He also directs a basic  research laboratory investigating mechanisms of inflammatory liver  injury and hepatic fibrogenesis, with a translational focus on  identification and development of potential hepatic antifibrotic agents.

Find out more about Professor William Sievert.

Our staff

Meet the people making waves in Liver/Gut Inflammation and Fibrosis Research.


Read and access our key publications.


If you are thinking of a career in biomedical research The School of Clinical Sciences is a great place to start. We are located at Monash Medical Centre (MMC) Clayton within easy walking distance of both Monash University Clayton Campus and the Clayton Shopping District.

Find out more about current postgraduate opportunities (Honours, Masters, PhD).